Poly Medicure Limited

Equities

531768

INE205C01021

Medical Equipment, Supplies & Distribution

Market Closed - Bombay S.E. 06:00:47 2024-04-24 am EDT 5-day change 1st Jan Change
1,557 INR +1.74% Intraday chart for Poly Medicure Limited -0.69% +4.42%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Poly Medicure Limited, Q3 2024 Earnings Call, Feb 02, 2024
Poly Medicure Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Poly Medicure Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Poly Medicure Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Poly Medicure Limited Proposes Dividend for the Financial Year 2022-23 CI
Poly Medicure Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Poly Medicure Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Poly Medicure Limited Appoints Ambrish Mithal as Independent Director CI
Poly Medicure Limited Recommends Dividend for the Year Ended March 31, 2022 CI
Poly Medicure Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Poly Medicure Limited Appoints Ravi Prakash as Deputy Company Secretary and Compliance Officer CI
Poly Medicure Limited Recommends Dividend for the Year 2021-2022 CI
Poly Medicure Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Poly Medicure Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Poly Medicure : Incorporates Step-Down Subsidiary in US MT
Poly Medicure Limited Announces Incorporation of Step-Down Subsidiary in USA CI
Certain Ordinary Shares of Poly Medicure Limited are subject to a Lock-Up Agreement Ending on 18-AUG-2021. CI
Poly Medicure Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Poly Medicure : Recommends Dividend for FY21 MT
Poly Medicure Limited Announces Change of CFO CI
Poly Medicure Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Poly Medicure Limited Recommends Dividend for the Year 2020-2021 CI
Poly Medicure Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Poly Medicure Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Poly Medicure Limited(BSE:531768) added to S&P Global BMI Index CI
Chart Poly Medicure Limited
More charts
Poly Medicure Limited is an India-based medical devices company. The Company is engaged in manufacturing and selling medical devices. The Company holds a portfolio of over 375 patents covering a range of products in various areas, including vascular access, renal care, transfusion and diagnostics systems. These products cater to a range of therapeutic segments, such as infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It supplies its products to more than 100 countries across Europe, Africa, the Americas, Australia, and Asia. Its products include IV cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others. It operates ten manufacturing facilities across India, China, Egypt and Italy.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1,557 INR
Average target price
1,748 INR
Spread / Average Target
+12.29%
Consensus
  1. Stock Market
  2. Equities
  3. 531768 Stock
  4. News Poly Medicure Limited
  5. Poly Medicure : Recommends Dividend for FY21